跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salveo® ODT - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Salveo® ODT
Approved
STANDARD
Salveo® ODT
Pharmathen SA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
73810c667aa7dc3e
Company
Pharmathen SA
Type
Standard
Approval Details
Approval Id
73810c667aa7dc3e
Drug Approval Philippines Name
Salveo® ODT
Product Name
Salveo® ODT
Registration Number
DRP-12303
Brand Name
Salveo® ODT
Generic Name
Olanzapine
Dosage Form
Orodispersible Tablet
Dosage Strength
5 mg
Manufacturer
Pharmathen SA
Importer
UNILAB, Inc.
Distributor
UNILAB, Inc.
Company Detail Path
/organization/pharmathen-sa
Issuance Date
13 July 2022
Expiry Date
13 July 2027
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
73810c667aa7dc3e
Type
Standard
Back to Philippines FDA Approvals